What Cartrex Treats: Main Uses and Benefits

Cartrex is used to provide symptomatic relief across key chronic conditions that involve pain and inflammation.

---

The medication is commonly applied across domains where additional symptomatic support is needed for persistent musculoskeletal discomfort, primarily in conditions presenting with systemic or localized discomfort such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is also relevant in acute contexts like low back pain, trauma, and dental procedures.

“This medication is applied in situations where symptoms create noticeable functional strain and interfere with daily comfort.”

It helps address symptom clusters that may become intense or disruptive, characterized by ongoing joint pain, physical stiffness, and localized swelling. This supports the patient during difficult episodes by easing distress and assists with maintaining a sense of stability when symptoms are more noticeable, which may also include managing symptoms related to elevated body temperature (fever) when present.

Quick Fact
Used for managing symptoms related to	Pain, Swelling, and Stiffness
Relevant in	Chronic Arthritis and Acute Injuries
Supports	Functional stability and helps ease the overall symptom burden

Regulatory References

1. UK Medicines and Healthcare products Regulatory Agency (MHRA)

Who can and cannot use Cartrex?

Cartrex (Aceclofenac) eligibility is strictly defined by regulatory documents, which classify populations based on existing health conditions and physiological status.

Contraindicated Populations (Must Not Use)

Use is absolutely prohibited for patients with:

• Established cardiovascular disease, including congestive heart failure (NYHA Class II-IV), ischaemic heart disease, and cerebrovascular disease.
• Severe hepatic or renal failure.
• Active, or history of recurrent, peptic ulceration or gastrointestinal bleeding related to prior non-steroidal anti-inflammatory drug (NSAID) therapy.
• A known hypersensitivity reaction to aceclofenac, aspirin, or other NSAIDs.
• The last trimester of pregnancy.

Populations Requiring Conditional Use

Close medical surveillance or caution is required for the following groups:

• The Elderly: Caution is advised due to an increased risk of serious adverse reactions and a higher likelihood of impaired organ function.
• Mild Organ Impairment: Patients with mild renal or mild to moderate hepatic function impairment must be kept under surveillance.
• Cardiovascular Risk: Individuals with mild congestive heart failure (NYHA-I) or significant cardiovascular risk factors should only be treated after careful consideration.

Age and Developmental Status

The medicine is indicated for adults. Use in the pediatric population is not recommended as clinical data in children are officially determined to be insufficient. Use while breastfeeding or during the first two trimesters of pregnancy is not recommended unless strictly necessary.

Interactions with other medicines and products

Official regulatory information for Cartrex focuses on avoiding combinations that may alter drug exposure or increase the risk of specific adverse effects, particularly those related to cardiac function and central nervous system activity.

Interacting Medicinal Product Categories

Interaction Domain	Key Constraint	Classification
Strong/Moderate CYP Enzyme Inhibitors	Use is generally avoided or requires dose adjustment.	Clinically Significant
Strong/Moderate CYP Enzyme Inducers	Avoid concomitant use due to reduced efficacy risk.	Clinically Significant
Other QT-Prolonging Agents	Concomitant use is generally contraindicated.	High Risk

Officially Documented Interaction Statements

• CYP Enzyme Interactions: Co-administration with medicinal products that strongly inhibit specific drug-metabolizing enzymes (e.g., CYP3A4, CYP2D6) can substantially increase Cartrex systemic exposure, leading to an elevated risk of concentration-dependent effects. Conversely, co-administration with strong inducers of these same enzymes may significantly decrease Cartrex plasma concentrations, potentially resulting in therapeutic failure.
• Cardiac-Related Agents: The combination with other agents known to prolong the QT interval must be avoided due to the potential for cumulative pharmacodynamic effects on cardiac repolarization.
• Food and Lifestyle Products: The use of alcohol is explicitly cautioned against due to the potential for additive effects on the central nervous system.

This interaction profile mandates that healthcare providers assess the patient’s full medication list for strong enzyme modifiers or other agents with cardiac effects. The necessity of avoiding or significantly modifying concurrent therapy under these conditions defines the essential interaction constraints for Cartrex, as specified in regulatory labeling.

Targeted Inhibition of the Prostaglandin Synthesis Cascade

The primary mechanism of Aceclofenac is the inhibition of the Cyclo-oxygenase ( COX) enzymes, demonstrating preferential targeting of the COX-2 isoform which becomes highly active during inflammation. By blocking COX-2, the drug prevents the conversion of Arachidonic Acid into Prostaglandins—local mediators that sensitize nociceptive nerve endings and elevate the body's central temperature setpoint in the hypothalamus. This core mechanism directly results in the modulation of nociceptive signal transmission and hypothalamic temperature setpoint adjustment.

COX-Independent Modulation of Inflammatory Response

Beyond prostaglandin suppression, Aceclofenac and its active metabolite engage in secondary COX-independent mechanisms that modulate inflammatory processes. These actions include the suppression of specific inflammatory cytokines (e.g., IL-1beta and TNFalpha) and interference with cell adhesion molecules (e.g., L-selectin), which restricts the recruitment of immune cells to tissue. This supplementary mechanism attenuates the impact of excessive mediator activity and contributes to altered inflammatory signaling within the targeted pathways, leading to a state of reduced vascular permeability at the tissue level.

Cartrex, an oral formulation containing the active ingredient Aceclofenac, is typically used according to schedules that define the administration and dosage limits. The medicine is administered via the oral route as a 100 mg film-coated tablet, which must be swallowed whole with liquid and should not be chewed or crushed. This procedural instruction is intended to ensure the proper functioning of the medication.

The standard adult usage pattern involves a total daily dose of 200 mg. This is typically achieved by taking 100 mg twice a day, or approximately every 12 hours. The total maximum daily dose is not to exceed 200 mg. Aligned with core usage principles, the drug is used at the lowest effective dose for the shortest possible duration necessary.

A key instruction regarding administration is the timing relative to meals: Cartrex is taken with or immediately after food.

Specific usage rules apply to certain populations. For older adults and individuals with mild renal impairment, no dose modification is generally required. However, for those with mild-to-moderate hepatic impairment, the standard dosing regimen is adjusted, with the initial daily dose reduced to 100 mg once daily. Use of Aceclofenac is generally not recommended in the pediatric population. The necessity for continued use is subject to periodic re-evaluation.

Research Evidence / Overview of Studies for Cartrex

The research base for the active ingredient in Cartrex, Aceclofenac, is documented in official regulatory sources and peer-reviewed scientific literature. The studies focus on characterizing how symptoms change in adults as reported in the studies with certain inflammatory conditions. The overall research landscape includes various types of trials, primarily Randomized Controlled Trials (RCTs) and systematic reviews.

---

Evidence for Use in Chronic Arthritis Conditions

This section summarizes the structure of the research base, mainly controlled trials and scientific reviews, that was studied for its application in chronic inflammatory conditions like osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The research generally examined measurements related to physical discomfort, pain intensity, and functional imbalance.

Evidence in Osteoarthritis Trials

The evidence stems primarily from short-term RCTs and several meta-analyses. Researchers monitored changes in key symptomatic indicators, such as overall pain level and how participants rated their daily functioning or activity level. The research provides limited information for long-term outcomes, as the follow-up durations were limited, generally extending only up to six months. Furthermore, evidence quality varies across studies.

Evidence in Rheumatoid Arthritis and Ankylosing Spondylitis Studies

Research was also evaluated in patient groups with rheumatoid arthritis and ankylosing spondylitis. Trials consistently documented the measured number of affected joints and the reported duration of morning stiffness. The research primarily provides short-term observation of measured symptomatic indicators. The studies primarily assessed measurements related to physical discomfort, rather than monitoring underlying disease progression.

---

What Research Gaps and Uncertainties Remain

A finding consistently noted is that the primary studies focused only on symptomatic observation and did not explore fundamental disease modification or reversal of joint damage. Research describes group patterns observed in the studies, and certainty remains low regarding very long-term functional stability, as this evidence is still emerging. Evidence quality varies across studies, and the research contributes to understanding symptom patterns but does not determine whether an individual will respond similarly.

Key Studies & References

1. Efficacy and Safety of Aceclofenac Controlled Release in Patients with Knee Osteoarthritis: A 4-week, Multicenter, Randomized, Comparative Clinical Study
2. Single dose oral aceclofenac for postoperative pain in adults. Cochrane Database of Systematic Reviews
3. IPAR HEALTH PRODUCTS REGULATORY AUTHORITY - Vitafen 100mg film-coated tablets (Aceclofenac) Summary of Product Characteristics
4. Summary Public Assessment Report Generics Aceclofenac Orion 100 mg film-coated tablets
5. Aceclofenac (Preservex): updated cardiovascular advice in line with diclofenac and COX-2 inhibitors - GOV.UK (MHRA)

Common questions about Cartrex (FAQ)

---

Q: How quickly does Cartrex typically start working?

According to official product information, the active ingredient in Cartrex is absorbed fairly quickly after being taken. Initial pain relief is typically described as beginning within 30 minutes to 1 hour after ingestion. This time frame represents the initial onset of action.

---

Q: How long do I need to wait to see the full effect of Cartrex?

The medicine is expected to reach its maximum concentration in the bloodstream approximately 1 to 3 hours after ingestion. The maximum concentration generally occurs 1 to 3 hours after a dose, which is when the most pronounced effect is observed.

---

Q: Is it safe to drink alcohol while taking Cartrex?

Regulatory documents explicitly caution against consuming alcohol while using this medication. Combining alcohol with Cartrex may lead to an increased risk of gastrointestinal side effects, such as stomach bleeding. There is also a potential for increased drowsiness due to possible additive effects on the central nervous system.

---

Q: Can Cartrex be used by children or teenagers?

The use of the medicine is generally not recommended for children and adolescents (typically under 18 years old). Official drug information indicates that there is insufficient clinical data to establish the safety and effectiveness of Cartrex in this specific age group.

---

Q: Can women who are planning to become pregnant use Cartrex?

Official regulatory warnings state that the use of Aceclofenac may impair female fertility. Because of this potential effect, the medicine is not recommended for women who are actively planning to conceive or who are undergoing fertility treatments.

---

Q: What should I do if a side effect of Cartrex doesn't go away?

While many common side effects are mild and temporary, if symptoms like indigestion or abdominal pain worsen or persist beyond an expected period, or if any unusual symptoms occur, official patient information suggests consulting a healthcare professional for further evaluation.

---

Q: Does Cartrex need to be stored in the refrigerator?

The official storage requirements state that the medicine should be kept protected from light and moisture, and stored below 25 C or 30 C depending on the formulation. Refrigeration is not required unless explicitly instructed by a pharmacist.

---

Q: Can Cartrex be crushed or mixed with food?

Regulatory instructions state that the tablet must be swallowed whole with water and should not be crushed or chewed. This administration instruction is necessary to ensure the medication is properly absorbed and functions as intended, while helping to avoid irritation.

---

Q: Can Cartrex be taken with food, or should it be taken on an empty stomach?

The medication is typically administered with food, or immediately following a meal. Official guidelines advise this practice to help protect the stomach lining and to minimize the risk of gastrointestinal side effects.

---

Q: What are the symptoms that indicate Cartrex is working?

The medication is intended to provide relief for pain and inflammation related to conditions like arthritis. Official sources indicate that the medicine functions by supporting a reduction in physical discomfort and swelling, along with improved functional movement or mobility in the affected areas.

---

Q: Why is consistency in taking Cartrex important?

The medicine is administered on a consistent schedule (e.g., twice daily) because its effect only lasts a few hours (half-life of about 4-5 hours). Consistent timing ensures a steady concentration in the body, which is necessary to maintain a continuous anti-inflammatory and pain-relieving action.

---

Q: Is it normal to feel no difference right after starting Cartrex?

While initial pain relief may begin within the first hour, the maximum therapeutic effect is generally not reached until 1 to 3 hours after a dose. It is expected that individual responses may vary, and the full benefit may require consistent use over a short period.

---

Q: Does Cartrex have a long-term effect or only when I'm taking it?

The medicine works by blocking specific chemical signals that cause pain and inflammation in the short term. Since the elimination half-life is relatively short (around 4–5 hours), the effects are primarily observed while the medicine is active in the body and do not typically persist long after the treatment stops.

---

Q: Can Cartrex cause tiredness or fatigue?

Official documentation reports effects on the central nervous system, listing dizziness and drowsiness (sleepiness) as potential side effects. These effects, although typically categorized as uncommon, may contribute to a feeling of tiredness.

---

Q: Do I need to change my diet while using Cartrex?

Core regulatory information mandates taking the medicine with food and advises avoiding alcohol due to safety concerns. Generally, no other specific dietary restrictions (such as avoiding certain food types) are listed in core regulatory documents.

---

Q: Does Cartrex interact with common pain relievers like ibuprofen or acetaminophen?

Official documents advise that the co-administration of Cartrex with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which includes common relievers like ibuprofen, must be avoided as this increases the risk of serious side effects. Use alongside paracetamol should also be assessed for toxicity risk.

---

Q: Is Cartrex safe for older adults (seniors)?

Official guidance notes that caution and close surveillance are required for older adults, as they are documented to be at a higher likelihood of adverse reactions, especially gastrointestinal bleeding, and must use the lowest effective dose for the shortest duration possible.

---

Q: What happens if I miss a scheduled dose of Cartrex?

Regulatory guidance states that if a dose is missed, the patient should skip the forgotten dose entirely and take the next scheduled dose at the usual time. It is specifically advised not to take a double dose to compensate for a missed tablet.

---

Q: What if I take too much Cartrex?

Symptoms of a potential overdose may include headache, nausea, vomiting, and stomach pain. Patients are advised in official warnings to contact a doctor or nearest hospital emergency department immediately if an overdose is suspected.

---

Q: Can Cartrex affect my sleep?

Regulatory documents list central nervous system effects such as dizziness and drowsiness as potential, though not always common, side effects. These documented effects can sometimes lead to altered sleep patterns.

---

Q: How long can a person safely use Cartrex?

Due to the potential for a small increased risk of serious adverse effects (such as cardiovascular events and GI bleeding) with prolonged use, the requirement is to use the lowest effective dose for the shortest duration necessary to manage symptoms. Official documents state that the need for continued use should be periodically re-evaluated.

---

Q: How is Cartrex eliminated from the body?

The medicine is processed into inactive compounds (metabolites) by the body. Approximately two-thirds of the administered dose is officially documented to be eliminated via the urine, and the remaining amount is eliminated via the feces.

---

Q: Is Cartrex a habit-forming medicine?

Cartrex is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). Official regulatory documentation does not classify Aceclofenac as a controlled substance or indicate that it has a potential for drug abuse or physical dependence.

---

Q: Does Cartrex cause sun sensitivity?

Severe skin reactions are listed as very rare adverse events in official documents. Photosensitivity reactions (increased sensitivity to sunlight) are a documented, though rare, class-effect possibility for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in general.

---

Q: Are there restrictions on specific foods while taking Cartrex?

Regulatory guidelines require the medicine to be taken with or after food to protect the stomach, but generally do not list restrictions on specific foods or nutrients in core official warnings or precautions.

---

Q: How long does Cartrex stay in your system after the last dose?

The medicine has a mean plasma elimination half-life of around 4 to 5 hours. Generally, the majority of the drug and its inactive forms are cleared from the body within about 24 hours after the last dose.

The official regulatory requirements dictate specific conditions for storing and disposing of Cartrex (Aceclofenac) tablets to ensure the product's quality and public safety.

Storage Conditions

Item	Official Regulatory Requirement
Temperature Requirements	Store below 30 C (86 F).
Protection Requirements	Protect from both light and moisture.
Container Requirements	Keep the medicine in the original package.
Child Safety	Must be kept out of the sight and reach of children.

Disposal Requirements

Official instructions prohibit disposing of unused or expired Cartrex via wastewater or household rubbish. Patients must consult a pharmacist for guidance on proper disposal, such as using a local medicine take-back program.